Billiontoone (NASDAQ:BLLN) Hits New 1-Year High – Still a Buy?

Billiontoone, Inc. (NASDAQ:BLLN) shares hit a new 52-week high on Wednesday . The stock traded as high as $144.27 and last traded at $142.5190, with a volume of 657338 shares. The stock had previously closed at $137.32.

Analysts Set New Price Targets

BLLN has been the subject of several analyst reports. JPMorgan Chase & Co. upped their price objective on Billiontoone from $120.00 to $125.00 and gave the company an “overweight” rating in a research note on Thursday, May 7th. Guggenheim initiated coverage on Billiontoone in a research note on Monday, June 29th. They set a “buy” rating and a $125.00 price target for the company. BTIG Research lowered their price objective on shares of Billiontoone from $140.00 to $130.00 and set a “buy” rating on the stock in a research report on Thursday, May 7th. Finally, Weiss Ratings raised Billiontoone from a “sell (d)” rating to a “sell (d+)” rating in a report on Tuesday, June 23rd. Six analysts have rated the stock with a Buy rating, three have assigned a Hold rating and one has assigned a Sell rating to the company’s stock. According to MarketBeat.com, Billiontoone currently has an average rating of “Moderate Buy” and a consensus price target of $126.00.

Billiontoone Stock Up 3.8%

The firm’s fifty day simple moving average is $115.55 and its 200-day simple moving average is $93.87. The company has a market cap of $6.56 billion and a PE ratio of 259.13. The company has a quick ratio of 10.58, a current ratio of 10.92 and a debt-to-equity ratio of 0.18.

Billiontoone (NASDAQ:BLLN) last issued its quarterly earnings data on Wednesday, May 6th. The company reported $0.34 earnings per share (EPS) for the quarter, topping the consensus estimate of $0.01 by $0.33. The company had revenue of $108.39 million for the quarter, compared to analyst estimates of $95.81 million. During the same quarter in the prior year, the firm earned ($0.39) earnings per share. The company’s revenue for the quarter was up 83.8% on a year-over-year basis. As a group, equities research analysts expect that Billiontoone, Inc. will post 0.92 earnings per share for the current fiscal year.

Insider Activity

In other Billiontoone news, insider Shan Riku Sakakibara sold 8,000 shares of the business’s stock in a transaction on Wednesday, June 24th. The stock was sold at an average price of $110.00, for a total value of $880,000.00. Following the completion of the transaction, the insider directly owned 208,000 shares in the company, valued at approximately $22,880,000. The trade was a 3.70% decrease in their position. The sale was disclosed in a legal filing with the SEC, which is accessible through this link. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, CTO David Tsao sold 20,000 shares of the firm’s stock in a transaction on Monday, June 15th. The stock was sold at an average price of $102.27, for a total value of $2,045,400.00. Following the sale, the chief technology officer owned 1,000 shares in the company, valued at $102,270. This trade represents a 95.24% decrease in their position. Additional details regarding this sale are available in the official SEC disclosure. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Over the last ninety days, insiders sold 157,049 shares of company stock worth $17,328,861. 50.22% of the stock is currently owned by corporate insiders.

Institutional Trading of Billiontoone

A number of hedge funds have recently added to or reduced their stakes in BLLN. Massachusetts Financial Services Co. MA purchased a new stake in Billiontoone in the 4th quarter valued at about $13,373,000. Baillie Gifford & Co. acquired a new stake in shares of Billiontoone in the fourth quarter worth approximately $103,786,000. Universal Beteiligungs und Servicegesellschaft mbH purchased a new stake in Billiontoone in the fourth quarter valued at approximately $1,348,000. UBS Group AG acquired a new position in Billiontoone during the fourth quarter worth approximately $2,586,000. Finally, Renaissance Capital LLC purchased a new position in Billiontoone during the fourth quarter worth approximately $201,000.

About Billiontoone

BillionToOne (NASDAQ: BLLN) is a molecular diagnostics company that develops and commercializes high-precision genetic testing solutions based on single-molecule counting technology. The company’s platform is designed to detect and quantify rare genetic variants and chromosomal abnormalities from cell-free DNA, with a primary focus on applications in prenatal screening and other clinical genetic tests where sensitivity and specificity at very low allele fractions are critical.

BillionToOne’s offerings center on assay development and clinical testing workflows that enable non-invasive prenatal testing (NIPT) and targeted molecular diagnostics.